| ID: | 201 | |
|---|---|---|
| Name: | Compound 201 | |
| Description: | Original numeration in publication: 6a | |
| Labels: | Training_set, Phthalazines | |
| CAS: | ||
| InChi Code: | InChI=1S/C16H12N6/c1-2-6-12(7-3-1)10-17-19-15-13-8-4-5-9-14(13)16-20-18-11-22(16)21-15/h1-11H,(H,19,21)/b17-10+ |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 5.84 |
El-Helby, A.-G. A.; Ayyad, R. R. A.; Sakr, H. a. E.-A., K.; Ali, M. M.; Khedr, F. Design, synthesis, molecular docking, and anticancer activity of phthalazine derivatives as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2017, 350, 1700240. https://doi.org/10.1002/ardp.201700240 |
| 5.86075 |
Eq1: VEGFR-2 inhibition (Data used to train model) |